Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography

Conditions

• Diabetic Retinopathy
• Macular Degeneration
• Retinal Disease

Eligibility Criteria

Sex

ALL

Age

5 Years - 110 Years

Healthy Volunteers

Accepted

Interventions

• SS-OCT system Plex Elite 9000 — DIAGNOSTIC_TEST
  We will use a commercially available SS-OCT system (Plex Elite 9000; Carl Zeiss Meditec).

Study Details

In this pilot study we want to investigate morphological features acquired by the novel image modality and gain information regarding disease pathomechanism, development and future possible influence on disease management for patients affected by those diseases.

Key Dates

First listed

Oct 10, 2023

Start date

Jun 1, 2017

Status verified

Oct 2023

Primary completion

Dec 31, 2025

Completion

Dec 31, 2026

Study Design

Enrollment

500 participants (estimated)

Primary Outcome Measure

Morphological changes using Swept Source Optical Coherence Tomography [ Time Frame: through study completion, an average of 1 year ]

Central Contacts

• Matthias Bolz, Prof. Dr.
  +43 (0)5 7680 83 - 1050
  [email protected]

Find similar trials

Related Studies

• Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene
  Recruiting · National Eye Institute (NEI) · Bethesda, Maryland
• Cell Collection to Study Eye Diseases
  Recruiting · National Eye Institute (NEI) · Bethesda, Maryland
• National Eye Institute Biorepository for Retinal Diseases
  Recruiting · National Eye Institute (NEI) · Bethesda, Maryland
• Inherited Retinal Degenerative Disease Registry
  Recruiting · Foundation Fighting Blindness · Columbia, Maryland